In subjects with T2DM, weekly administration of tirzepatide at doses of 5 mg, 10 mg, or 15 mg was associated with greater weight loss compared to placebo ( 6.3 kg, 8.4 kg, and 9.4 kg, respectively), and 1.7 kg, 4.8 kg, and 7.2 kg greater weight loss compared to selective GLP-1 receptor agonists, demonstrating a dose-dependent effect sustained for up to 2 years [48]
An anti-DSIP antibody has the potential to restore red blood cell function by forcing the immature cells to make mature ones
Its the safest and most effective way to explore what these peptides can do for you
The main advantage here is that it allows for finer control over smaller doses, as each unit on the syringe contains less active peptide
Most published research is from the 1980s1990s
Read about my experience with it over the last several weeks in my product review down below